banner
Apoptosis activator 2, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ077

Apoptosis activator 2, Purity ≥98%

Synonym: 79183-19-0; Apoptosis Activator 2; MDK83190; 1-(3,4-Dichlorobenzyl)indoline-2,3-dione; 1-(3,4-Dichlorobenzyl)-1H-indole-2,3-dione; Caspase activator

  • MDL: MFCD00141556
  • CAS Number: 79183-19-0
  • Compound CID: 1901244
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Apoptosis activator 2, soluble in DMSO and insoluble in ethanol and water, is an active small molecule compound that mediates the caspase signaling pathway. It targets Caspase-3.
Molecular Weight
306.1
Molecular Formula
C15H9Cl2NO2
Targets
Caspase-3
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 53 mg/mL (173.12 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Apoptosis activator 2 can be used to induce apoptosis in cancer cells, aiding in the study of potential cancer treatments.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0